• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Asthma: still a promising future?哮喘：仍有充满希望的未来？
Eur Respir Rev. 2014 Dec;23(134):405-7. doi: 10.1183/09059180.00009614.
2
Revisiting asthma therapeutics: focus on WNT signal transduction.重新审视哮喘治疗学：关注 WNT 信号转导。
Drug Discov Today. 2018 Jan;23(1):49-62. doi: 10.1016/j.drudis.2017.09.001. Epub 2017 Sep 7.
3
Medication compliance in adults with asthma.成人哮喘患者的药物依从性。
Am J Nurs. 1999 Mar;99(3):45-6.
4
New concepts in the pathogenesis and treatment of allergic asthma.过敏性哮喘发病机制与治疗的新概念
Mt Sinai J Med. 1998 Sep;65(4):246-56.
5
Knowledge of inflammatory cytokines and mediators in asthma: what is its importance in clinical practice?哮喘中炎症细胞因子和介质的知识：其在临床实践中的重要性是什么？
Monaldi Arch Chest Dis. 1997 Feb;52(1):86-8.
6
Leukotriene modifiers. Expanded role may be on horizon.白三烯调节剂。其作用范围可能即将扩大。
Adv Nurse Pract. 2000 Oct;8(10):42-6.
7
Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms.哮喘患者的先天性和适应性T细胞：与疾病严重程度和发病机制的关系。
J Allergy Clin Immunol. 2015 Aug;136(2):323-33. doi: 10.1016/j.jaci.2015.01.014. Epub 2015 Mar 5.
8
Monoclonal antibodies for chronic refractory asthma and pipeline developments.用于慢性难治性哮喘的单克隆抗体及研发进展。
Drug Discov Today. 2012 Jun;17(11-12):591-9. doi: 10.1016/j.drudis.2012.01.012. Epub 2012 Jan 25.
9
Unmet needs in the pharmacological treatment of asthma.哮喘药物治疗中未满足的需求。
Pulm Pharmacol Ther. 1999;12(2):63-5. doi: 10.1006/pupt.1999.0197.
10
Recent advances in the pathophysiology of asthma.哮喘病理生理学的最新进展。
Chest. 2010 Jun;137(6):1417-26. doi: 10.1378/chest.09-1895.

引用本文的文献

1
Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis.在意大利定义2型哮喘及适合使用度普利尤单抗的患者：基于生物标志物的分析
Clin Mol Allergy. 2021 May 21;19(1):5. doi: 10.1186/s12948-021-00146-9.
2
Effect of on PM10-Induced Inflammatory Response of Human Lung Epithelial Cells.[未提及的因素]对PM10诱导的人肺上皮细胞炎症反应的影响。
Evid Based Complement Alternat Med. 2020 Sep 7;2020:2893609. doi: 10.1155/2020/2893609. eCollection 2020.
3
Cold Stimuli Facilitate Inflammatory Responses Through Transient Receptor Potential Melastatin 8 (TRPM8) in Primary Airway Epithelial Cells of Asthmatic Mice.冷刺激通过瞬时受体电位 melastatin 8（TRPM8）促进哮喘小鼠气道上皮细胞的炎症反应。
Inflammation. 2018 Aug;41(4):1266-1275. doi: 10.1007/s10753-018-0774-y.
4
The effects of interleukin-33 on airways collagen deposition and matrix metalloproteinase expression in a murine surrogate of asthma.白细胞介素-33对哮喘小鼠模型气道胶原沉积和基质金属蛋白酶表达的影响。
Immunology. 2018 Feb 18;154(4):637-50. doi: 10.1111/imm.12911.
5
Somatic extracts of Marshallagia marshalli downregulate the Th2 associated immune responses in ovalbumin-induced airway inflammation in BALB/c mice.马氏马歇尔线虫的体细胞提取物可下调卵清蛋白诱导的BALB/c小鼠气道炎症中与Th2相关的免疫反应。
Parasit Vectors. 2017 May 12;10(1):233. doi: 10.1186/s13071-017-2159-8.
6
Nasal airway epithelial cell IL-6 and FKBP51 gene expression and steroid sensitivity in asthmatic children.哮喘儿童鼻气道上皮细胞白细胞介素-6和FKBP51基因表达及类固醇敏感性
PLoS One. 2017 May 11;12(5):e0177051. doi: 10.1371/journal.pone.0177051. eCollection 2017.
7
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?瑞利珠单抗与嗜酸性粒细胞性哮喘：离精准医学更近一步了吗？
Front Immunol. 2017 Mar 10;8:242. doi: 10.3389/fimmu.2017.00242. eCollection 2017.
8
Bronchial Epithelial Cells from Asthmatic Patients Display Less Functional HLA-G Isoform Expression.哮喘患者的支气管上皮细胞显示出功能性HLA - G异构体表达较少。
Front Immunol. 2017 Jan 23;8:6. doi: 10.3389/fimmu.2017.00006. eCollection 2017.
9
Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma.糖皮质激素在激素抵抗型哮喘患者中性粒细胞中的抗炎作用受损。
Respir Res. 2016 Nov 16;17(1):153. doi: 10.1186/s12931-016-0462-0.
10
Role of biologics in severe eosinophilic asthma - focus on reslizumab.生物制剂在重度嗜酸性粒细胞性哮喘中的作用——聚焦于瑞利珠单抗。
Ther Clin Risk Manag. 2016 Jul 1;12:1075-82. doi: 10.2147/TCRM.S111862. eCollection 2016.

本文引用的文献

1
Bronchial thermoplasty: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults.支气管热成形术：治疗成人重度、难治性哮喘的一种新的治疗选择。
Eur Respir Rev. 2014 Dec;23(134):510-8. doi: 10.1183/09059180.00005114.
2
Mepolizumab treatment in patients with severe eosinophilic asthma.美泊利珠单抗治疗严重嗜酸性粒细胞性哮喘患者。
N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8.
3
Bronchial thermoplasty: reappraising the evidence (or lack thereof).支气管热成形术：重新评估证据（或缺乏证据）。
Chest. 2014 Jul;146(1):17-21. doi: 10.1378/chest.14-0536.
4
Prognostic value of cluster analysis of severe asthma phenotypes.聚类分析严重哮喘表型的预后价值。
J Allergy Clin Immunol. 2014 Nov;134(5):1043-50. doi: 10.1016/j.jaci.2014.04.038. Epub 2014 Jun 27.
5
The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia.美泊利珠单抗在伴有持续性嗜酸性粒细胞增多的特应性和非特应性重度哮喘中的作用
Eur Respir J. 2014 Jul;44(1):239-41. doi: 10.1183/09031936.00220413. Epub 2014 Mar 23.
6
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.国际 ERS/ATS 指南：严重哮喘的定义、评估和治疗。
Eur Respir J. 2014 Feb;43(2):343-73. doi: 10.1183/09031936.00202013. Epub 2013 Dec 12.
7
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis.严重真菌性哮喘和变应性支气管肺曲霉病的治疗选择。
Eur Respir J. 2014 May;43(5):1487-500. doi: 10.1183/09031936.00139513. Epub 2013 Dec 5.
8
Anti-interleukin-5 therapy in severe asthma.抗白细胞介素-5 治疗严重哮喘。
Eur Respir Rev. 2013 Sep 1;22(129):251-7. doi: 10.1183/09059180.00004013.
9
Bronchial thermoplasty: a novel therapy for severe asthma.支气管热成形术：一种治疗严重哮喘的新疗法。
Clin Chest Med. 2013 Sep;34(3):437-44. doi: 10.1016/j.ccm.2013.03.003. Epub 2013 Aug 1.
10
Bronchial epithelium as a target for innovative treatments in asthma.支气管上皮细胞作为哮喘创新治疗的靶点。
Pharmacol Ther. 2013 Dec;140(3):290-305. doi: 10.1016/j.pharmthera.2013.07.008. Epub 2013 Jul 21.

Asthma: still a promising future?

作者信息

Chanez Pascal, Humbert Marc

机构信息

Respiratory Medicine APHM, INSERM U1067, Aix-Marseille University, Marseille, France. Service de Pneumologie, Université Paris-Sud, AP-HP, Hôpital Bicêtre, Inserm U999, Le Kremlin Bicêtre, France

Respiratory Medicine APHM, INSERM U1067, Aix-Marseille University, Marseille, France. Service de Pneumologie, Université Paris-Sud, AP-HP, Hôpital Bicêtre, Inserm U999, Le Kremlin Bicêtre, France.

出版信息

Eur Respir Rev. 2014 Dec;23(134):405-7. doi: 10.1183/09059180.00009614.

DOI:10.1183/09059180.00009614
PMID:25445937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9487413/
Abstract
摘要